Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1283075-60-4 | MDL No. : | MFCD26402019 |
Formula : | C7H3Cl2N3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BIULHHKFNLFURG-UHFFFAOYSA-N |
M.W : | 200.02 | Pubchem ID : | 77231154 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.35 |
TPSA : | 38.67 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.06 cm/s |
Log Po/w (iLOGP) : | 1.57 |
Log Po/w (XLOGP3) : | 2.06 |
Log Po/w (WLOGP) : | 2.33 |
Log Po/w (MLOGP) : | 1.25 |
Log Po/w (SILICOS-IT) : | 2.73 |
Consensus Log Po/w : | 1.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.99 |
Solubility : | 0.203 mg/ml ; 0.00101 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.5 |
Solubility : | 0.631 mg/ml ; 0.00316 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.19 |
Solubility : | 0.0128 mg/ml ; 0.0000641 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.85 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In tetrahydrofuran; water; at 20℃; for 72h; | A solution of of 4.81 g (27 mmol) <strong>[24484-99-9]4,6-dichloro-pyridine-2,3-diamine</strong> (synthesis described in J. E. Schelling, C. A. Salemink, Rec. Trav. Chim. Pays-Bas 91 , 650 [1972]) in 50 ml THF was treated with 5.22 g (27 mmol) of a 30percent solution of glyoxal in water and the mixture was stirred for 3 days at room temperature. The reaction mixture was evaporated and the residue was partitioned between dichloromethane and diluted sodium carbonate solution. The organic phase was dried over sodium sulfate and evaporated. The residue was chromatographed on a silica gel column with cyclohexane/ethyl acetate as eluent yielding 6,8-dichloro- pyrido[2,3-b]pyrazine as off-white fine needles; HPLC/MS (B): 1.93 min, [M+H] 200. 1H NMR (400 MHz, CDCI3) delta = 9.16 (d, J=1.7, 1 H), 9.05 (d, J=1.7, 1H), 7.89 (s, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium hydrogencarbonate;bis-triphenylphosphine-palladium(II) chloride; In tetrahydrofuran; water; at 80.0℃; for 16h;Inert atmosphere; | A solution of 1.60 g (8.00 mmol) <strong>[1283075-60-4]6,8-dichloro-pyrido[2,3-b]pyrazine</strong>, 1.12 g (8.00 mmol) 2-fluorophenylboronic acid and 961 mg (9.60 mmol) potassium hydrogen carbonate in 16 ml THF and 1.6 ml water was heated to 80 C under nitrogen. Then 112 mg (0.16 mmol) bis-(triphenylphosphine)-palladium(ll)-chloride were added and the mixture was stirred for 16 hrs at 80 C. Water was added to the reaction mixture and the precipitate was filtered off, dried in vacuum and recrystallized from 2-propanol: 8-chloro-6-(2-fluoro-phenyl)-pyrido[2,3-b]pyrazine as slightly yellow crystals; HPLC/MS (B): 2.68 min, [M+H] 260.H NMR (400 MHz, CDCI3) delta = 9.08 (d, J=1.7, 1H), 8.96 (d, J=1.7, 1H), 8.36 (d, =1.4, 1 H), 8.27 (td, J=7.9, 1.8, 1 H), 7.45 (m, 1 H), 7.28 (m, 1 H), 7.17 (ddd, J=11.6, 8.3, 0.8, 1H). |
[ 2089292-97-5 ]
5,7-Dichloro-2-methyl-1H-imidazo[4,5-b]pyridine
Similarity: 0.85